Payment overview · 2025
General Payments
$29.96
1 reported records · 1 companies
Healthcare provider profile · identity verified
Manmeet K Bains, MD
Allopathic & Osteopathic Physicians|Family Medicine · RACINE, WI · NPI 1104144781
Verified facts
What the public records show
CMS Open Payments records show Manmeet K Bains, MD received $29.96 in general payments during 2025 across 1 reported records.
Dynavax Technologies Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dynavax Technologies Corporation | Unresolved — no canonical attribution shown | $29.96 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $29.96 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Heplisav-B Normalized: heplisav b |
Drug | Dynavax Technologies Corporation | $29.96 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 556 | 120 |
| Atorvastatin Calcium | Atorvastatin Calcium | 523 | 121 |
| Levothyroxine Sodium | Levothyroxine Sodium | 326 | 71 |
| Lisinopril | Lisinopril | 277 | 61 |
| Omeprazole | Omeprazole | 277 | 68 |
| Potassium Chloride | Potassium Chloride | 204 | 48 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 201 | 60 |
| Pantoprazole Sodium | Pantoprazole Sodium | 195 | 40 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 190 | 47 |
| Losartan Potassium | Losartan Potassium | 175 | 37 |
| Gabapentin | Gabapentin | 168 | 44 |
| Hydrochlorothiazide | Hydrochlorothiazide | 161 | 38 |
| Metformin Hcl | Metformin Hcl | 161 | 42 |
| Furosemide | Furosemide | 145 | 31 |
| Montelukast Sodium | Montelukast Sodium | 132 | 28 |
| Trazodone Hcl | Trazodone Hcl | 131 | 27 |
| Metoprolol Succinate | Metoprolol Succinate | 127 | 34 |
| Sertraline Hcl | Sertraline Hcl | 126 | 29 |
| Simvastatin | Simvastatin | 118 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 114 | 26 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 108 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 97 | 21 |
| Carvedilol | Carvedilol | 92 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 88 | 31 |
| Meloxicam | Meloxicam | 88 | 14 |
| Alendronate Sodium | Alendronate Sodium | 86 | 22 |
| Eliquis | Apixaban | 82 | 12 |
| Metformin Hcl Er | Metformin Hcl | 82 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 81 | 15 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 80 | 64 |
| Glipizide | Glipizide | 77 | 16 |
| Alprazolam | Alprazolam | 75 | 12 |
| Metoprolol Tartrate | Metoprolol Tartrate | 74 | 20 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 67 | 18 |
| Lorazepam | Lorazepam | 63 | 14 |
| Warfarin Sodium | Warfarin Sodium | 56 | 13 |
| Clopidogrel | Clopidogrel Bisulfate | 55 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 54 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 53 | 16 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 51 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 50 | 11 |
| Ibuprofen | Ibuprofen | 49 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 48 | 19 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 48 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 47 | 15 |
| Tramadol Hcl | Tramadol Hcl | 47 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 47 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 45 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 44 | suppressed |
| Ozempic | Semaglutide | 43 | 11 |
| Solifenacin Succinate | Solifenacin Succinate | 42 | suppressed |
| Synthroid | Levothyroxine Sodium | 41 | suppressed |
| Famotidine | Famotidine | 40 | suppressed |
| Topiramate | Topiramate | 40 | suppressed |
| Trulicity | Dulaglutide | 40 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 37 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 36 | 36 |
| Linzess | Linaclotide | 36 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 36 | suppressed |
| Januvia | Sitagliptin Phosphate | 35 | suppressed |
| Orenitram Er | Treprostinil Diolamine | 35 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 35 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 35 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 33 | suppressed |
| Estradiol | Estradiol | 32 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 32 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 32 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 30 | 21 |
| Prednisone | Prednisone | 29 | 20 |
| Nystatin | Nystatin | 28 | 11 |
| Ezetimibe | Ezetimibe | 27 | suppressed |
| Ketoconazole | Ketoconazole | 27 | suppressed |
| Ramipril | Ramipril | 27 | suppressed |
| Allopurinol | Allopurinol | 26 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 26 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 26 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 26 | suppressed |
| Aripiprazole | Aripiprazole | 25 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 25 | suppressed |
| Bupropion Xl | Bupropion Hcl | 25 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 25 | suppressed |
| Azithromycin | Azithromycin | 24 | 22 |
| Breo Ellipta | Fluticasone/Vilanterol | 24 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 23 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 22 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 22 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Amoxicillin | Amoxicillin | 21 | 19 |
| Clonazepam | Clonazepam | 21 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 21 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 21 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 20 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 20 | suppressed |
| Atenolol | Atenolol | 19 | suppressed |
| Baclofen | Baclofen | 19 | suppressed |
| Jardiance | Empagliflozin | 19 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 19 | suppressed |
| Spironolactone | Spironolactone | 19 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 18 | suppressed |
| Epinephrine | Epinephrine | 18 | suppressed |
| Lovastatin | Lovastatin | 18 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 18 | suppressed |
| Tradjenta | Linagliptin | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 16 | 14 |
| Latanoprost | Latanoprost | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 15 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 15 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 15 | suppressed |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 14 | 14 |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 14 | suppressed |
| Mirtazapine | Mirtazapine | 14 | suppressed |
| Premarin | Estrogens, Conjugated | 14 | suppressed |
| Cilostazol | Cilostazol | 13 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 13 | suppressed |
| Loperamide | Loperamide Hcl | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 13 | suppressed |
| Wegovy | Semaglutide | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Celebrex | Celecoxib | 12 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Sure Comfort Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 11 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 11 | suppressed |
| Pregabalin | Pregabalin | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Trulance | Plecanatide | 11 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $29.96 · 1 records | Dynavax Technologies Corporation | Heplisav-B | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error